Quick Answer
Corteva, Inc. reported Research And Development Expense of $1.47 billion for the year ending 2025.
- Corteva, Inc. showed an increase of +5.1% in Research And Development Expense from 2024 to 2025.
- This data is from Corteva, Inc.'s annual report (Form 10-K), filed with the SEC on February 12, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2017: $484.00 million | Q1 2018: $382.00 million | Q2 2018: $354.00 million | Q3 2018: $325.00 million | Q1 2019: $299.00 million | Q2 2019: $269.00 million | Q3 2019: $289.00 million | Q1 2020: $280.00 million | Q2 2020: $273.00 million | Q3 2020: $284.00 million | Q1 2021: $281.00 million | Q2 2021: $293.00 million | Q3 2021: $297.00 million | Q1 2022: $268.00 million | Q2 2022: $296.00 million | Q3 2022: $312.00 million | Q1 2023: $316.00 million | Q2 2023: $329.00 million | Q3 2023: $335.00 million | Q1 2024: $332.00 million | Q2 2024: $357.00 million | Q3 2024: $348.00 million | Q1 2025: $335.00 million | Q2 2025: $375.00 million | Q3 2025: $351.00 million.
- Over the full 8 years of available data (2018 to 2025), Corteva, Inc.'s Research And Development Expense has grown by 8.8%.
- Historical annual values: Fiscal year 2025: $1.47 billion | Fiscal year 2024: $1.40 billion | Fiscal year 2023: $1.34 billion | Fiscal year 2022: $1.22 billion | Fiscal year 2021: $1.19 billion | Fiscal year 2020: $1.14 billion | Fiscal year 2019: $1.15 billion | Fiscal year 2018: $1.36 billion.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: